Neuland Laboratories Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹776.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 76.54 per cent from ₹439.71 crore. This corresponds to a year-on-year *(YoY) growth of 136.40 per cent.
Operating Profit
Operating Profit stands at ₹307.33 crore, reflecting a quarter-on-quarter *(QoQ) increase of 298.46 per cent from ₹77.13 crore. This corresponds to a year-on-year *(YoY) growth of 501.78 per cent.
PBDT
PBDT stands at ₹312.58 crore, reflecting a quarter-on-quarter *(QoQ) increase of 298.75 per cent from ₹78.39 crore. This corresponds to a year-on-year *(YoY) growth of 456.29 per cent.
Profit Before Tax
Profit Before Tax stands at ₹287.49 crore, reflecting a quarter-on-quarter *(QoQ) increase of 427.80 per cent from ₹54.47 crore. This corresponds to a year-on-year *(YoY) growth of 631.53 per cent.
Net Profit
Net Profit stands at ₹212.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 424.21 per cent from ₹40.57 crore. This represents a 664.72 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Neuland Laboratories Ltd Earnings
- YOY
- QOQ
Neuland Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Neuland Laboratories Ltd Research Reports
Neuland Laboratories Ltd Financial Reports
Neuland Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Neuland Labs. | 2.42% | 2.82% | 5.30% | 29.81% | 51.52% | 37.34% |
| Sai Life | 4.61% | 3.11% | 3.28% | 22.17% | 55.71% | 55.29% |
| Rubicon Research | 2.84% | 6.65% | 10.16% | 60.68% | 130.37% | 148.98% |
| Piramal Pharma | 6.02% | 8.47% | 15.24% | 19.92% | 24.99% | -6.61% |
| Pfizer | 1.97% | 1.44% | 6.99% | -1.16% | 2.38% | -10.83% |
| Granules India | 1.22% | -1.25% | 5.26% | 19.59% | 47.00% | 72.10% |
| Astrazeneca Phar | 2.10% | 1.68% | 1.41% | -2.54% | -2.59% | -8.78% |
Company Info
Company Information
Chairman & Exec. Director : D R Rao
Vice Chairman / Executive Director / WTD : D Sucheth Rao
Non Independent ED / MD / CEO / Promoter : D Saharsh Rao
Independent Non Exe. Director : Homi R Khusrokhan
Independent Non Exe. Director : P R Menon
Independent Non Exe. Director : Sugata Sircar
Independent Non Exe. Director : Pallavi Joshi Bakhru
Independent Non Exe. Director : Ravi Gopinath
Non Executive Director : Mauricio Futran
Company Sec. & Compli. Officer : Sarada Bhamidipati